London (Nov. 22)-The European Medicines Agency reports a defect in some vials of Herceptin (trastuzumab), the anticancer treatment by Roche, which have been distributed in Europe. As a result, The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback